[1]
Anas Babar 2025. Comment on Khan S P Khan, et al. (J Pak Med Assoc. 74: 1654-1658, September 2024) Role of Oral Hypoglycaemic Drugs in Preventing Complications in Non-Alcoholic Fatty Liver Disease with Type 2 Diabetes Mellitus. Journal of the Pakistan Medical Association. 75, 02 (Jan. 2025), 349–349.